Biodesix, Inc. (BDSX)
Nasdaq · Common stock · Services-Medical Laboratories
As of Oct 21, 3:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow BDSX in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on BDSX and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
BDSX at a glance
Key statistics
$251.86M
Market capitalization
- Previous close
- $23.87
- Open
- $23.90
- Day range
- $23.68 – $24.74
- Volume
- 38.0K
- Average volume (30 sessions)
- 89.3K
- Shares outstanding
- 10.55M
- Earnings per share
- $(2.63)
- Price / book
- 27.5
- Price / sales
- 2.5
- Beta (1 year, vs SPY)
- 0.94
Where the price sits in its year
52-week range
70% of the range
- Below the 52-week high
- -24.6%
- Above the 52-week low
- +358.0%
Completed sessions through Oct 20, 2026
Technical snapshot
Below its 50-day average, above its 200-day
- 20-day average
- $26.88-11.2%
- 50-day average
- $26.63-10.4%
- 200-day average
- $18.03+32.4%
Between the conventional 30 and 70 bands.
-4.5%
1 week
-16.0%
1 month
+11.6%
3 months
+251.0%
Year to date
+271.8%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with BDSX
BDSX on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on BDSX.
See the plans →
Every planScreen names like BDSX
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on BDSX
Put BDSX on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on BDSX
See whether there is an open premium alert on BDSX, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
BDSX headlines
- Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
GlobeNewswire Inc. · Oct 19, 2026
- Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
GlobeNewswire Inc. · Oct 13, 2026
- Biodesix to Participate in Upcoming Investor Conferences
GlobeNewswire Inc. · Sep 3, 2026
- Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
GlobeNewswire Inc. · Jul 22, 2026
- Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
GlobeNewswire Inc. · Apr 20, 2026
- Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc. · Feb 12, 2026
- Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
GlobeNewswire Inc. · Jan 12, 2026
- Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
GlobeNewswire Inc. · Sep 5, 2025
SEC Form 4, most recent first
Insider filings
PATIENCE JOHN
−1.4K
Director · Option exercise
· Sep 30, 2026
PATIENCE JOHN
+1.4K
Director · Option exercise
· Sep 30, 2026
SCHULER JACK W
+15.0K
10% owner · Open-market purchase
$366.99K · Aug 12, 2026
SCHULER JACK W
+13.7K
10% owner · Open-market purchase
$328.91K · Aug 11, 2026
SCHULER JACK W
+13.9K
10% owner · Open-market purchase
$337.03K · Aug 10, 2026
PATIENCE JOHN
−1.4K
Director · Option exercise
· Jun 30, 2026
PATIENCE JOHN
+1.4K
Director · Option exercise
· Jun 30, 2026
PATIENCE JOHN
−1.4K
Director · Option exercise
· Mar 31, 2026
About Biodesix, Inc.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Services-Medical Laboratories
- Headquarters
- Louisville, CO
- Employees
- 334
- Listed since
- Oct 28, 2020
- Website
- biodesix.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.